Shock

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 35

SHOCK

Shibila.V.P
Final year MBBS
Introduction
Types and Causes
Pathogenesis
Stages of shock
Clinical features
Management
What is shock ?
“Shock is a state in which
diminished cardiac output
or reduced effective
circulating blood volume
impairs tissue perfusion and
leads to cellular hypoxia.”
• Acute circulatory failure
• Life threatening clinical syndrome of cardiovascular
collapse
• Hypotension and Hypoperfusion
• First reversible damage
• Prolonged shock - irreversible cell injury and death.
Cardiogenic primary pump failure
shock
Hypovolemic Low blood volume
shock

SHOCK
Peripheral
vasodilation

Distributive
Types
shock
Septic
Anaphylactic
Neurogenic

Obstructive Obstruction to blood


shock flow
Type of Causes Principal Mechanism
Shock
Cardiogenic Myocardial infarction Decreased cardiac output due to
Ventricular arrhythmias Failure of myocardial pump resulting
shock Myocarditis from intrinsic myocardial damage,
Aortic stenosis extrinsic compression, or obstruction
Mitral regurgitation to flow.

Hypovolemic Fluid loss Decreased cardiac output due to


(Hemorrhage, vomiting, diarrhea, inadequate blood or plasma volume
shock burns etc. )

Distributive Overwhelming microbial infections, Widespread vasodilation leading to


Trauma, Pancreatitis, IgE mediated reduced systemic vascular
shock hypersensitivity reactions, Anesthetic resistance and hypotension
accidents, brain or a spinal injury,
Obstructive shock
 Due to extracardiac obstruction to blood flow
 Heart pumps well, but due to obstruction cardiac output is
reduced.
 Cardiac tamponade, pulmonary embolism, pericardial
effusion, tension pneumothorax
PATHOPHYSIOLOGY
 Inadequate perfusion.
 Compensatory mechanism, Catecholamines.
 Effective only in early stages.
 Tissue hypoxia
 Anaerobic metabolism, Lactic acid accumulation
 Cell membrane dysfunction
PATHOPHYSIOLOGY
 Release of toxic substances and proteolytic enzymes
 Toxic substances enter circulation
 Endothelial damage
 Activation of inflammatory and coagulation cascade
 Vasodilator substance, Hypotension
 SIRS, MODS, Death
PATHOGENESIS OF
DIFFERENT TYPES
OF SHOCK
STAGES OF SHOCK Initial
Deterioration of circulation is a
progressive and continuous phenomenon,
compensatory mechanism will eventually Compensatory
become less effective.

 Initial stage ( insult )


Progressive
 Compensatory shock ( Preshock )
 Progressive stage ( Shock )
 Refractory stage ( End-organ Refractory
Dysfunction)
Hypovolemic shock
 Most common form of shock
 MC cause of death following fractures of major bones.
 Pelvis and Femur
 Hemorrhagic or non-hemorrhagic
 External or internal hemorrhage
 Pelvis – 1500-2000 mL
 Femur – 1000-1500 mL
CLINICAL FEATURES OF SHOCK
 Fast and feeble peripheral pulse
 Hand and feet- pale, cool, and clammy.
 Decreased urine output
 Lethargy, confusion, restlessness and somnolence common
 Tachypnoea, Tachycardia
 Cyanosis may be present
 Low BP
CLINICAL FEATURES OF SHOCK
 Septic shock- Skin may be warm, or fever may be
present
 Cardiogenic shock- May have chest pain, Dyspnoea
 Anaphylactic shock- May have angioedema, urticaria,
Wheezing
Effects of SHOCK
 Heart – Decreased CO, Tachycardia, Hypotension
 Respiratory – Interstitial oedema, Decreased gas exchange,
ARDS and Pulmonary oedema.
 Renal – Decreased GFR, tubular reabsorption of salt and water
increases for compensatory response. But in severe case
Tubular necrosis
 Hepatic – Raised liver enzymes, Failure to metabolize waste
products, Jaundice
 CNS – Hypoperfusion leads to drowsiness. ( Brain is the last
organ to get under perfused )
 Endocrine – ADH , Increased reabsorption of water.
 Metabolic – Lactic acidosis
 Cellular changes – Due to release of lysosomal enzymes which
alters the cell membrane permeability, sickle cell syndrome
 Blood – Alteration in cellular components, Coagulation
abnormalities ( DIC )
 GIT – Mucosal ischemia, Bleeding from GIT, Malena and
hematemesis.
MANAGEMENT

Goals of management
 Treat reversible causes
 Improve cardiac function
 Improve tissue perfusion
Laboratory investigations
• Lactic acid
• Complete blood count and differential
• Renal function test
• Liver function test
• Urine analysis and urine sediment
• Arterial blood gas
• ECG, Echocardiography
• PT, PTT
MONITORING FOR PATIENTS IN SHOCK
MINIMUM
 ECG
 Pulse oximetry
 Blood pressure
 Urine output
ADDITIONAL MODALITIES
 Central venous pressure
 Invasive blood pressure
 Cardiac output
 Basic deficit and serum lactate
General principles of management
 Preferably treated in ICU
 ECG monitoring
 Pulse oximetry
 Successful resuscitation-Reduction in serum lactate
level.
Resuscitation
• Shouldn’t be delayed
• If there is initial doubt – assume the cause is
hypovolemia and start fluid resuscitation
• IV fluid should be given through short, wide bore
catheters
• If blood is lost – ideal replacement is blood,
crystalloid therapy required while awaiting for
blood products
INITIAL ASSSESMENT – ABC
A – Airway
GCS less than 8 – intubate
Secure airway, if unable to maintain give oxygen
Airway compromised in anaphylaxis
B- Breathing
If patient is conversing A and B are fine
May need mechanical ventilation
C- Circulation
Restore perfusion.
IV Fluids – continuous monitor
• 2 large bore peripheral IV access – 18/16
• Begin resuscitation with rapid infusion of 500mL-
1L RL or isotonic NS
• Continue resuscitation with IV fluids, blood
products, or both
• Hemorrhagic shock – After initial liter of IV fluid,
PCV, Fresh frozen plasma, and platelets to
replace lost blood
• Type specific blood, in emergency O-ve packed
cells can be given
Fluid therapy
 Crystalloid solutions – Increase intravascular volume
-Ringer lactate solution
-Normal saline
-Hartmann’s solution
 Colloid solutions – Pull fluid into the vascular spaces
through osmosis
 Blood transfusions
 Cardiogenic – Inotropes, vasodilators, intra-aortic balloon pump.

 Obstructive jaundice – Urgent relief of obstruction

Tension pneumothorax – needle thoracostomy

Cardiac tamponade – pericardiocentesis

Massive pulmonary embolism is difficult to treat.


 Neurogenic shock– High dose steroids, to decrease
inflammation ,treat the symptoms
 Anaphylactic shock - Airway management
epi 0.5-1mg IM or 50-100 microg IV
 Septic shock – Fluid administration
Monitor VS
Broad spectrum antibiotics
Vasopressors
Vasopressor and Inotropic support
 Vasopressor agents indicated in distributive shock
 phenylephrine, Dopamine, Noradrenaline
 Resistant to catecholamines, vasopressin can be
used.
 Cardiogenic shock, inotropic therapy is required
increase cardiac output
 DOC is Dobutamine
End point resuscitation
Heart rate < 100 / min
Blood pressure of 90/60 mmHg
Oxygen saturation of 93-95%

 As perfusion improves, aim is to normalize homeostasis


 Final end point of resuscitation – normal base deficit
( eliminate metabolic acidosis)
 Achieved within 12-24 hours of admission
 Hypovolemic shock -

You might also like